Arovella Therapeutics Receives Positive Feedback From US FDA for Blood Cancer Treatment; Shares Jump 7%
Arovella Therapeutics Receives Positive Feedback From US FDA for Blood Cancer Treatment; Shares Jump 7%
Arovella Therapeutics因治疗血癌获美国FDA的积极反馈；股价上涨7%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间